GENE DELETION - A NEW TARGET FOR CANCER-CHEMOTHERAPY

被引：18

作者：

FREI, E

机构：

[1] Department of Medicine, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115

来源：

LANCET | 1993年 / 342卷 / 8872期

关键词：

D O I：

10.1016/0140-6736(93)91764-D

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：662 / 664

页数：3

共 50 条

[21] CANCER-CHEMOTHERAPY
不详
[J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 1985, 27 (681): : 13 - 20
[22] CANCER-CHEMOTHERAPY
不详
[J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 1987, 29 (736): : 29 - 36
[23] CANCER-CHEMOTHERAPY
不详
[J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 1989, 31 (793): : 49 - 56
[24] CANCER-CHEMOTHERAPY
CAIRNS, J
BOYLE, P
[J]. SCIENCE, 1983, 220 (4594) : 252 - &
[25] NEW NATURAL-PRODUCTS IN CANCER-CHEMOTHERAPY
SLICHENMYER, WJ
VONHOFF, DD
[J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 30 (09): : 770 - 788
[26] CANCER-CHEMOTHERAPY - NEW DEVELOPMENTS AND CHANGING CONCEPTS
CARTER, SK
[J]. DRUGS, 1980, 20 (05) : 375 - 397
[27] ALTERED TUMOR METHIONINE ADENOSYLTRANSFERASES - A SELECTIVE TARGET FOR CANCER-CHEMOTHERAPY
SUFRIN, JR
LOMBARDINI, JB
[J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 19 - 19
[28] HYPOXIC TUMOR-CELL - TARGET FOR SELECTIVE CANCER-CHEMOTHERAPY
KENNEDY, KA
TEICHER, BA
ROCKWELL, S
SARTORELLI, AC
[J]. BIOCHEMICAL PHARMACOLOGY, 1980, 29 (01) : 1 - 8
[29] ANTHRACYCLINES IN CANCER-CHEMOTHERAPY
DIMARCO, A
[J]. DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, 1983, 9 (11) : 751 - 765
[30] PRODRUGS IN CANCER-CHEMOTHERAPY
WILMAN, DEV
[J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 1986, 14 (02) : 375 - 382